Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Completed · Phase 1/Phase 2 · Has a placebo group
Conditions studied: Bacteremia, Staphylococcus Aureus, Staphylococcus Aureus Bacteremia, Bacteremia Staph, Bacteremia Due to Staphylococcus Aureus
In brief
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic Therapy Alone for the Treatment of Adults With Bacteremia Due to Staphylococcus aureus
Key facts
- Study ID
- NCT05184764
- Run by
- Armata Pharmaceuticals, Inc.
- People needed
- 56
- Starts
- 2022-04-26
- Expected to finish
- 2025-01-14
- Last updated by the study team
- 2026-03-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner University Medical Center — Tucson, Arizona, United States
- University of California, San Diego (UCSD) - Medical Center — La Jolla, California, United States
- University of Southern California Keck School of Medicine — Los Angeles, California, United States
- University of California, Los Angeles (UCLA) - Medical Center — Los Angeles, California, United States
- Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center — Torrance, California, United States
- Rocky Mountain Regional VA Medical Center — Aurora, Colorado, United States
- University of Florida (UF) - Division of Infectious Disease — Gainesville, Florida, United States
- University of Florida - Jacksonville — Jacksonville, Florida, United States
- University of South Florida — Tampa, Florida, United States
- Emory University Hospital Midtown — Atlanta, Georgia, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- Tufts Medical Center — Boston, Massachusetts, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Henry Ford Health System — Detroit, Michigan, United States
- The Jamaica Hospital Medical Center — Jamaica, New York, United States
- Icahn School of Medicine at Mount Sinai — New York, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
- University of North Carolina - Chapel Hill School of Medicine — Chapel Hill, North Carolina, United States
- Wake Forest University Health Sciences — Winston-Salem, North Carolina, United States
- Rhode Island Hospital — Providence, Rhode Island, United States
- Regional One Healthcare — Memphis, Tennessee, United States
- Methodist Hospital Research Institute - Houston — Houston, Texas, United States
- Froedtert Hospital and the Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Royal Adelaide Hospital — Adelaide, Australia
- Monash Health — Clayton, Australia
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.